Blog
Feb 24

AHA, Merck, Novartis, J&J & CareSet

Amongst the improved programming of SXSW healthcare, CareSet’s SXSW panel is sandwiched between AHA and Merck events.  The infamous Fred Trotter moderates a discussion about new school cardiovascular care lead by four executive experts.  We are all affected and will be there.
Date: March 10th, 2018
Time: 11:00AM
Duration: 60 minutes
Venue: Austin Convention Center
Room: 6AB

Description: New school medical diagnostics and interventions aim to reduce unnecessary procedures, making the procedures that remain far less invasive while ensuring that hard to detect conditions get treatment earlier. The healthcare system needs innovators to make money by lowering costs overall, putting the pressure on traditional inefficient approaches and making space for innovators to shine.

Panelists –

  1. Cat Oyler, Global Head, Strategy & Operations at Johnson & Johnson

  2. Swapnil Rajpathak, Executive Director, Center for Observational and Real World Evidence (CORE) at Merck

  3. David Soergel MD, Global Head, Drug Development Cardiovascular and Metabolic Diseases at Novartis

  4. Patrick Wayte, VP Marketing and Health Education at American Heart Association

  5. Fred Trotter, CareSet (moderator)

 

Note: The Session Description is subject to modification pending panelist interview.
Ashish

About The Author

Ashish is co-founder of CareSet Systems. An entrepreneur and healthcare data transparency advocate, Ashish also founded the DocGraph Journal, bringing together the Healthcare Data Science community along with Politico and ProPublica to publish data sets for scientific advancement. Ashish is currently working to decode Medicare Claims data for Pharmaceutical companies, helping analyze provider teaming, and building robust networks.